Lygos
Lygos engineers yeast to convert sugar into high-value industrial…
San Francisco, United States · $38.6M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Website
- lygos.com
- Total Funding
- $38.6M
- Last Round
- $5.0M Venture RoundJan 2019
- Rounds
- 8
About
Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.
Summary
Lygos is a Biotech company based in San Francisco, United States. It has raised $38.6M in total across 8 rounds, most recently a $5.0M Venture Round round in Jan 2019.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Sign up to see all 8 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...